EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension

Elena A Goncharova iD, Tatiana V Kudryashova iD, Vinicio A de Jesus Perez iD, Olga Rafikova

Circulation Research · 2023

DOI: 10.1161/circresaha.123.322912 ↗

Kurz gefasst

Editorial in der Zeitschrift Circulation Research, 2023. Verfasst von Elena A Goncharova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lung Center, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis School of Medicine, Davis, CA (E.A.G., T.V.K.). Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Hypertension, Pulmonary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a severe and progressive chronic disease characterized by a high mortality rate, poor prognosis, and limited treatment options (1).PAH is defined by a mean pulmonary artery (PA) pressure greater than 20 mmHg at a rest, a pulmonary vascular resistance (PVR) greater than 2 Wood Units, and PA wedge pressure of 15 mmHg or less.The primary pathophysiological features of PAH include constriction of medium to large-sized PAs and obstructive remodeling or depletion of small PAs (2), resulting in a substantial reduction in the blood vessel cross-sectional lumen area, a considerable escalation in the right ventricle's (RV's) afterload, and RV failure (1, 2).The underlying mechanisms driving PAH are complex and multifactorial, encompassing various genetic, environmental, and physiological factors that interact to precipitate disease onset and progression (1, 3).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Arterial HypertensionHypertension, PulmonaryHumansWnt Signaling PathwayHeartThoraxPrognosisPulmonary Artery

Stichwörter der Autor:innen

Editorialchronic diseaseconstrictionprognosispulmonary arterial hypertension

Autor:innen und Institutionen

  • Lung Center, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis School of Medicine, Davis, CA (E.A.G., T.V.K.).
  • Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, CA (V.A.d.J.P.).
  • Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ (O.R.).

ORCID-Profile: Elena A Goncharova, Tatiana V Kudryashova, Vinicio A de Jesus Perez

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Goncharova, E. A., Kudryashova, T. V., de Jesus Perez, V. A., & Rafikova, O. (2023). UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension. Circulation Research. https://doi.org/10.1161/circresaha.123.322912

Vancouver

Goncharova EA, Kudryashova TV, de Jesus Perez VA, Rafikova O. UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension. Circulation Research. 2023. doi:10.1161/circresaha.123.322912

BibTeX
@article{Goncharova2023,
  author = {Goncharova, Elena A and Kudryashova, Tatiana V and de Jesus Perez, Vinicio A and Rafikova, Olga},
  title = {UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension},
  journal = {Circulation Research},
  year = {2023},
  doi = {10.1161/circresaha.123.322912}
}
Kostenlos starten →